[1] Choukroun J, Adda F, Schoeffler C, et al. Une opportunité en paro-implantologie: le PRF[J]. Implantodontie, 2001,42:55-62. [2] Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin(PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006, 101(3):e37-e44. [3] Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006, 101(3):e56-e60. [4] Simonpieri A, Del Corso M, Sammartino G, et al. The relevance of Choukroun's platelet-rich fibrin(PRF) and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: Implant surgery, prosthodontics and survival[J]. Implant Dent, 2009,18(3):220-229. [5] Diss A, Dohan DM, Mouhyi J, et al. Osteotome sinus floor elevation using Choukroun's platelet-rich fibrin as grafting material: a 1-year prospective pilot study with microthreaded implants[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008,105(5):572-579. [6] Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: Platelet-related biologic features[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006, 101(3):e45-e50. [7] Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006,101(3):299-303. [8] Meyer C, Chatelain B, Benarroch M, et al. Massive sinus-lift procedures with beta-tricalcium phosphate: long-term results[J]. Rev Stomatol Chir Maxillofac, 2009, 110(2):69-75. [9] Lee HJ, Choi BH, Jung JH, et al. Maxillary sinus floor augmentation using autogenous bone grafts and platelet-enriched fibrin glue with simultaneous implant placement[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103(3):329-333. [10] Mazor Z, Horowitz RA, Del Corso M, et al. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months[J]. J Periodontol, 2009, 80(12):2056-2064. [11] 李玮, 李坤阳, 范云, 等. 富血小板纤维蛋白对人牙周膜成纤维细胞迁移及成骨分化的影响[J]. 郑州大学学报(医学版), 2014, 49(1):108-112. [12] 杨世茂, 王明国, 李静, 等. 富血小板纤维蛋白与富血小板血浆体外释放生长因子的比较及其对脂肪干细胞增殖分化的影响[J]. 华西口腔医学杂志, 2012, 30(6):641-644. [13] 徐炜, 王明国, 马锋, 等. 富血小板纤维蛋白对兔脂肪干细胞成骨分化的影响[J]. 口腔生物医学杂志, 2013, 4(1): 19-21. [14] Day TF, Guo X, Garrett-Beal L, et al. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis[J]. Dev Cell, 2005, 8(5):739-750. [15] Rodda SJ, McMahon AP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors[J]. Development, 2006, 133(16):3231-3244. [16] Laudes M . Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes[J]. J Mol Endocrinol, 2011, 46(2):R65-R72. [17] Bennett CN, Ross SE, Longo KA,et al. Regulation of Wnt signaling during adipogenesis[J]. J Biol Chem, 2002, 277(34):30998-31004. [18] Ross SE, Hemati N, Longo KA, et al. Inhibition of adipogenesis by Wnt signaling[J]. Science, 2000, 289(5481):950-953. [19] Etheridge SL, Spencer GJ, Heath DJ, et al. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells[J]. Stem Cells, 2004, 22(5):849-860. [20] Pandur P, Maurus D, Kühl M. Increasingly complex: new players enter the Wnt signaling network[J]. Bioessays, 2002, 24(10):881-884. |